Many antidepressants inhibit serotonin or norepinephrine reuptake or both to achieve their clinical effect. The selective serotonin reuptake inhibitor class of antidepressants (SSRIs) includes citalopram, escitalopram (active enantiomer of citalopram), fluoxetine, fluvoxamine, paroxetine, and sertraline. The SSRIs are as effective as tricyclic antidepressants in treatment of major depression with less significant side effects. As a result, they have become the largest class of medications prescribed to humans for depression. They are also used to treat obsessive-compulsive disorder, panic disorders, alcoholism, obesity, migraines, and chronic pain. An SSRI (fluoxetine) has been approved for veterinary use in treatment of canine separation anxiety. SSRIs act specifically on synaptic serotonin concentrations by blocking its reuptake in the presynapse and increasing levels in the presynaptic membrane. Clinical signs of SSRI overdose result from excessive amounts of serotonin in the central nervous system. These signs include nausea, vomiting, mydriasis, hypersalivation, and hyperthermia. Clinical signs are dose dependent and higher dosages may result in the serotonin syndrome that manifests itself as ataxia, tremors, muscle rigidity, hyperthermia, diarrhea, and seizures. Current studies reveal no increase in appearance of any specific clinical signs of serotonin toxicity with regard to any SSRI medication. In people, citalopram has been reported to have an increased risk of electrocardiographic abnormalities. Diagnosis of SSRI poisoning is based on history, clinical signs, and response to therapy. No single clinical test is currently available to confirm SSRI toxicosis. The goals of treatment in this intoxication are to support the animal, prevent further absorption of the drug, support the central nervous system, control hyperthermia, and halt any seizure activity. The relative safety of the SSRIs in overdose despite the occurrence of serotonin syndrome makes them more desirable than other antidepressants. The prognosis in animals that receive treatment is excellent. In one retrospective study, there were no deaths in 313 SSRI-poisoned dogs. No characteristic or classic histopathologic lesions result from SSRI toxicosis. Differential diagnoses for SSRI overdose must include ingestions of other serotonergic medications such as phenylpiperidine opioids (fentanyl and tramadol), mirtazapine, buspirone, amitraz, and chlorpheniramine.
Introduction
Beginning in the last half of the twentieth century, depression became recognized as a pervasive and widespread problem in Western societies. According to a study by the Centers for Disease Control and Prevention, antidepressant use in the United States increased 5 times between 1988 and 2008. 1 In addition, a remarkable 11% of American adults admitted to having taken prescription antidepressants between 2005 and 2008. 1,2 A variety of medications have been utilized in the treatment of depression including tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), and a number of atypical antidepressants. Most antidepressants work through the inhibition of serotonin or norepinephrine reuptake or both as a means through which they achieve their therapeutic effects. 3 In addition, in the past 50 years, the neurotransmitter serotonin has become recognized as central in the development and treatment of clinical depression. As a result, along with the tricyclic antidepressants, a number of medications have been developed to manipulate the amount of serotonin available in the central nervous system (CNS). These include the serotonin reuptake inhibitors (SSRIs), serotonin agonists, and serotonin antagonists, which all have been utilized and prescribed for a wide number of human psychiatric illnesses. 2 At present, SSRIs are still considered a first-line therapy treatment of depression. 4 Additionally, SSRIs are used to treat obsessivecompulsive disorders, panic disorder, alcoholism, obesity, anxiety, and various psychological disorders such as migraine headache syndromes and chronic pain. 5 SSRIs are just as effective as the tricyclic antidepressants for treatment of major clinical depression and have less significant side effects. 6, 7 The relative safety of the SSRIs when ingested in overdose, compared with the monoamine oxidase inhibitors (MAOIs) and cyclic antidepressants, also makes them a more optimal and desirable choice for therapy. As a result, SSRIs have become the largest class of prescribed medication in the treatment of clinical depression. 3 The class of SSRIs includes fluvoxamine (Luvox), citalopram (Celexa), escitalopram (Lexapro-the active enantiomer of citalopram), fluoxetine (Prozac in humans; Reconcile in veterinary medicine), paroxetine (Paxil), and sertraline (Zoloft). In veterinary medicine, SSRIs are used (frequently in off-label use) for a wide variety of behavioral issues, which has included feline spraying, lick granuloma control, and especially for treatment of canine separation anxiety. 8 In 2007, the first specific veterinary SSRI (Reconcile) was approved by the Food and Drug Administration for treatment of canine behavioral problems, specifically separation anxiety. 9 In this discussion, we examine the state of our understanding of the SSRIs, and investigate their mechanism of action, pathophysiology, toxic dose, clinical signs, treatment, and prognosis for affected animals.
Toxic Dose
Despite their widespread use and easy availability, there is surprisingly little information in previous reports to accurately define a minimum acute dosage of any SSRI. A number of studies and review articles have included data concluding that SSRIs, as a class, have a wide margin of safety, particularly when compared with tricyclic antidepressants and monoamine oxidase inhibitors. 10, 11 One study in humans conducted by a panel from the reported to cause seizures. In children, ingestions of 400-500 mg total have been shown to lead to the serotonin syndrome. For children, there was 1 reported death with a single ingestion of 2.5 g, but another child who ingested 13.5 g and developed clinical signs recovered uneventfully after treatment. Table 1 shows therapeutic human dosages for SSRIs. Table 2 shows lowest dosage of SSRIs to cause moderate to severe toxicity in humans. Table 3 shows median dose ingested to cause symptomatic SSRI poisoning in animals (dogs).
Toxicokinetics and Mechanism of Action
The SSRIs are a chemically diverse group of agents that share the ability to inhibit the presynaptic uptake of serotonin within the CNS. These drugs are commonly prescribed for treatment of mild to moderate depression, anxiety disorders, obsessivecompulsive behaviors, migraines, and other neuropathic pain. 12, 13, 14 Manipulation of serotonin and norepinephrine has a central role in the treatment of depression. However, the exact etiology of depression and the mechanism by which increased serotonergic and norepinephrine neurotransmission modulates mood and temperament remains unclear. Depression has been theorized to be caused by decreased neuronal serotonin storage, decreased synaptic serotonin, increased serotonin receptor sensitivity, and serotonin overactivity resulting in depressed dopamine neurotransmission. 15, 16, 17 Serotonin is a biogenic amine produced from the essential amino acid tryptophan. The majority of the body's serotonin is synthesized within the CNS and enterochromaffin cells. Serotonin within the CNS is stored in the presynaptic vesicles of the serotonergic neurons, pineal gland, and catecholaminergic neurons. The presynaptic membrane releases serotonin and binds to serotonin-specific receptors on the postsynaptic membrane. In addition, serotonin may bind to autoreceptors on the presynaptic membrane, which acts as a negative feedback to further serotonin release. Serotonin is removed from the synaptic cleft by binding to a selective serotonin transporter. This molecule transports the serotonin into the presynaptic cytosol. 17 Once there, the serotonin is metabolized by monoamine oxidase (MAO) or repackaged in vesicles. 18 The effect at the postsynaptic membrane is determined by the amount of serotonin available to bind 5-hydroxytryptamine (5-HT) receptors. 19 Antidepressant agents specifically targeted at altering CNS concentrations of serotonin are from 1 of 4 groups. 3 Firstly, there are antidepressant These medications are responsible for a variety of adverse effects because of their antihistaminergic and antimuscarinic actions. 20 The tricyclic antidepressants in particular can cause quinidinelike proarrhythmic myocardial effects and cause alpha-adrenergic blockades that may lead to hypotension. 3 SSRIs act more specifically on synaptic serotonin concentrations with minimal effects on catecholamine, acetylcholine, and histamine. 2 This specificity of SSRIs minimizes the adverse effects seen with MAOIs and tricyclic antidepressants. 20 Subsequently, the SSRIs have largely replaced the once widely prescribed tricyclic antidepressants because of their comparative safety and less frequent adverse effects. Thus, as a result of their high safety profile and fewer troublesome side effects, SSRIs are currently the first-line therapy prescribed for depression. 11 SSRIs are available only through prescription of a licensed veterinarian or physician. All of the SSRIs are wellabsorbed after oral ingestion. Fluoxetine, paroxetine, and sertraline are the most protein bound. All SSRIs are metabolized in the liver. 8 The SSRIs have numerous active metabolites. Fluoxetine's active metabolite, norfluoxetine, has very similar pharmacologic effects to the parent molecule. The SSRIs have diverse elimination patterns, however, most are excreted in the urine with sertraline excreted in the bile in dogs. 8 
Clinical Signs
Most effects following severe overdose with SSRIs are direct extensions of their pharmacologic activity in therapeutic doses. 3 Excess serotonergic stimulation is a prominent feature and is generally nonselective. Short-term clinical signs with an overdose in humans are dizziness, nausea, vomiting, and blurred vision, and it may cause CNS depression and sinus tachycardia. 3 Seizures and QS complex prolongation have been reported. 12 In dogs, at lower dosages, hypersalivation, anorexia, agitation, vomiting, and tremors are typically observed. 8 Vomiting, diarrhea, weakness, ataxia, nystagmus, head tilt, bradycardia, aggressive behavior, tremors, and seizures have all been described in dogs upon significant SSRI overdose. 8 The signs are dose dependent and usually appear within 1 hour. 11 In addition, the higher the dose ingested, the greater the chances for development of the serotonin syndrome. 11 It may be better termed ''serotonin toxicity''. This is a potentially life-threatening complication of antidepressant drug therapy. 3 It often goes unidentified due to its nonspecific symptoms. This is a clinical syndrome that manifests itself as autonomic instability, altered mental status, seizures, and extrapyramidal syndrome including muscle rigidity and hyperthermia. 11 Dogs with serotonin syndrome display multiple signs including mental status changes, agitation, myoclonus, hyperreflexia, shivering, tremors, vomiting, diarrhea, and hyperthermia. 2 The syndrome is produced most often by the concurrent use of 2 or more xenobiotics that increase serotonin activity in the CNS. Simultaneous use of SSRIs and cocaine, methadone, tramadol, and even the herbal medication St. Johns Wort have all been implicated in causing serotonin syndrome. 3 A partial list of drugs with potential for serotonin syndrome is included in Table 4 . In humans and dogs, it has been reported that most patients recover from serotonin syndrome after 24 hours of discontinuing the SSRI and initiating supportive care. 21, 22 For all SSRIs, hyperthermia and gastrointestinal and neurologic signs are the most common clinical manifestations of overdose. 2, 8 In a recent retrospective study in dogs, there was no statistical difference between different SSRI medications and the type of clinical signs that developed. 2 Thus, there was no statistical difference between the medications with regard to the frequency of the appearance of a particular clinical sign. For SSRIs, the clinical signs that develop appear stereotyped. Citalopram and its enantiomer escitalopram have been reported to be more likely to cause QT interval widening-related cardiac issues and the development of seizures in people. 12 These effects are directly dose related. In humans, SSRI overdose rarely results in life-threatening effects but fatalities have been recorded. In 1 human fatality, the patient ingested 75 times 3 the recommended maximum daily dose of fluoxetine.
One recent study of SSRIs in dogs reported no fatalities 2 recorded in more than 300 animals poisoned in a 5-year period. In some dogs, GI upset and CNS signs have been noted when fluoxetine was used at therapeutic doses for separation anxiety treatment. These effects in dogs may represent mild serotonin toxicity. 9 In most cases, the initial onset of clinical signs following SSRI ingestion is within a few hours. 2, 11, 23 Onset of the serotonin syndrome is usually within 6 hours of ingestion, with an escalating severity of clinical signs. 11 Recently, considerable evidence has accumulated that the SSRI escitalopram causes fewer seizures in cases of human overdose than the SSRI citalopram. 12 This may make escitalopram a safer drug in cases of overdose but this finding has not been confirmed in animal studies. 2 Table 5 summarizes the clinical signs seen in dogs following SSRI toxicity. For both humans and animals, the clinical signs observed after SSRI overdose are the result of excessive serotonin in the CNS.
Minimum Database and Confirmatory Tests
Currently, no diagnostic test capable of determining if an animal is suffering from SSRI overdose is available. Although tremoring and seizuring animals in life-threatening cases can be 12 A history including the availability of an SSRI to the dog, witnessing the ingestion, or the presence of tablets or capsules in the vomitus can all aid in obtaining a correct diagnosis. In dogs, the most common clinical effects in symptomatic animals were GI and CNS signs. 2, 23 Likewise, the clinical signs manifested by this toxidrome (lethargy, salivation, hyperthermia, mydriasis, vomiting, diarrhea, cardiovascular signs, rigidity, tremors, and seizures) must be noted and identified for the early recognition of SSRI overdose. Although definitive diagnostic tests are lacking, the time-tested triad of history, clinical signs, and laboratory results should never be underestimated in helping confirm the diagnosis of a particular toxicosis.
Treatment
Just as in any poisoning, initiation of treatment must not supersede the essentials of emergency medicine. Temperature, respiration, heart rate and rhythm must all be strictly monitored and never overlooked. The treatment of patients with SSRI intoxication is largely supportive. Although there is no known specific antidote and the vast majority of SSRI poisonings recover uneventfully, initiation of supportive therapy is essential, particularly if other causes may be at work. Asymptomatic animals may be induced to vomit if ingestion has occurred within the last hour (apomorphine 0.04 mg/kg IV). The goals of therapy in SSRI overdose are to prevent further absorption of the drug, counter the GI signs, support the CNS, and provide further support. Activated charcoal (1 mg/kg) may be useful to help absorb any drug remaining in the GI tract. 8, 11 Although intravenous fluids do not hasten the elimination or excretion of SSRIs, they are necessary to replace GI losses, support the cardiovascular system, bring down the body temperature, and maintain adequate tissue perfusion. 8 Patients should be monitored regularly to check for hyperthermia. Basic blood work (CBC and biochemical panel) and urinalysis should be performed to rule out other concurrent problems. Regular electrocardiograms should be performed to identify any cardiac arrhythmias. 12 The animal should be observed closely for development of serotonin syndrome-agitation, hyperthermia, vomiting, diarrhea, hypertension, hyperreflexia, muscle rigidity, tachycardia, tremors, and seizures. Animals experiencing SSRI overdose should be placed on a regular seizure watch. Tremors may be managed with methocarbamol (55-220 mg/kg IV) given slowly to effect. 8 Seizures stemming from this intoxication can be controlled with phenobarbitol (3-5 mg/kg IV) or diazepam (0.25 to 0.5 mg/kg IV). Intractable seizures can be stopped using either propofol, 2-6 mg.kg IV, or continuous rate infusion at 0.6 mg/kg/ min IV. Propofol dosage can be decreased by 25% if phenothiazines (acepromazine or chlorpromazine) have previously been given. If seizures continue with IV phenobarbitol and propofol, they should be halted using inhalant isoflurane. Benzodiazapines have been reported in one study to actually exacerbate the serotonin syndrome and associated agitation. 8 We have not witnessed this effect and find benzodiazepines useful in treatment of SSRI toxicosis. Agitation itself should be regulated through the use of phenothiazines such as acepromazine (0.05-0.1 mg/kg given SQ, IM, or IV) or chlorpromazine (0.5-1.0 mg/kg IV or IM given slowly and starting at the lower end of the range). Phenothiazines must be utilized keeping in mind that they may lower the animal's seizure threshold and that benzodiazepines may be safer. If serotonin syndrome develops, cyproheptadine can be given to animals with severe clinical signs at the following dosages: for dogs, 1.1 mg/kg (given orally) and for cats, 2.0-4.0 mg total dose (given every 6 hours until clinical signs resolve). 8 Amitraz collars (and in other forms) should not be employed for several weeks following SSRI toxicity. In humans, many features overlap between the serotonin syndrome and the neuroleptic malignant syndrome. 3 Altered mental status, ataxia, incoordination, and tremors resulting in hyperthermia are common clinical signs in both syndromes. However, neuroleptic malignant syndrome involves rapid blockage of dopaminergic neurons in the CNS, whereas serotonin syndrome is thought to follow severe overstimulation of serotonin receptors. Neuroleptic malignant syndrome can last for as long as 2 weeks whereas serotonin syndrome generally resolves quickly. Currently, it is not known whether the neuroleptic malignant syndrome actually occurs in animals. 8 Table 6 summarizes SSRI-overdose therapy.
Prevention and Prognosis
Despite the appearance of serotonin syndrome in some cases, the SSRIs as a group are relatively safe in overdose situations. 21 In one retrospective study, no dogs (sample size ¼ 313) were should be encouraged to bring in the original containers for any human medications. There may be a 1-800 number or manufacturer information with regard to poisoning.
Gross and Histologic Lesions
There are no specific, pathognomic histologic lesions seen in SSRI overdose. 8 A vast majority of animals survive and show no long-term effects.
Differential Diagnoses
The tricyclic antidepressant clomipramine used in veterinary medicine for behavioral problems has also been implicated in causing the serotonin syndrome and should not be used in conjunction with the SSRIs. 8 Other serotonergic medications causing similar clinical signs to SSRIs include phenylpiperidine opioids (fentanyl, tramadol, etc.), buspirone, duloxetine, mirtazapine, buspirone, amitraz, and chlorpheniramine. These other serotonergic agents should not be used in conjunction with the SSRIs. However, generally these other agents work through receptors other than just serotonin and as a result have very different clinical signs. A high index of suspicion is required to confirm a diagnosis of SSRI intoxication, particularly when other drugs may be the culprit or when the avenue of ingestion or exposure is not immediately evident. Laboratory tests can be critical but the strength of a thorough physical examination must not be underestimated! Animals ingesting toxic compounds rank among the most challenging cases small animal clinicians face. Nevertheless, through the prudent utilization of available resources (local toxicology laboratories, local hospitals, local toxicologists, regional veterinary colleges, the national poison hotline (800-222-1222), the animal poisoning hotline (888-426-4435), and an awareness of current literature and treatment protocols) many potentially life-threatening exposures can have successful outcomes.
